Akinori Miyashita

Chuo, 9518585, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

A reappraisal of APOE genetic effects on Alzheimer's disease risk in the Japanese population: a meta-analysis.

A reappraisal of APOE genetic effects on Alzheimer's disease risk in the Japanese population: a meta-analysis.

Journal: Molecular neurodegeneration

Published: April 07, 2026

Reductions in regional cerebral blood flow and dopamine transporter uptake in a patient with Gerstmann-Sträussler-Scheinker disease harboring the prion protein gene P105L mutation.

Reductions in regional cerebral blood flow and dopamine transporter uptake in a patient with Gerstmann-Sträussler-Scheinker disease harboring the prion protein gene P105L mutation.

Journal: Journal of the neurological sciences

Published: March 16, 2026

Reduced Soluble Ubiquilin2 in Amyotrophic Lateral Sclerosis Carrying Ubiquilin2 (P494L) Mutation: Clinicopathological and Biochemical Evidence From an Autopsy Case.

Reduced Soluble Ubiquilin2 in Amyotrophic Lateral Sclerosis Carrying Ubiquilin2 (P494L) Mutation: Clinicopathological and Biochemical Evidence From an Autopsy Case.

Journal: Neuropathology and applied neurobiology

Published: March 13, 2026

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations.

Journal: Frontiers in molecular neuroscience

Published: February 23, 2026

Expansive spatial pattern of Aβ deposition in patients with cerebral amyloid angiopathy: A three-dimensional surface-to-depth analysis.

Expansive spatial pattern of Aβ deposition in patients with cerebral amyloid angiopathy: A three-dimensional surface-to-depth analysis.

Journal: Science advances

Published: February 06, 2026

APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analyses.

APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analyses.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 05, 2026

Early onset Alzheimer's disease with V180I variant of prion protein gene and a family history of dementia: a case report.

Early onset Alzheimer's disease with V180I variant of prion protein gene and a family history of dementia: a case report.

Journal: BMC neurology

Published: January 17, 2026

The First Autopsy-Proven Case of CSF1R-Related Leukoencephalopathy Harboring the p.Cys774Arg Mutation.

The First Autopsy-Proven Case of CSF1R-Related Leukoencephalopathy Harboring the p.Cys774Arg Mutation.

Journal: Neuropathology : official journal of the Japanese Society of Neuropathology

Published: January 16, 2026

APOE*4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic Analyses.

APOE*4 Risk-Modifying Genes and Drug Targets in Alzheimer's Disease through Cell-Type Specific Genomic Analyses.

Journal: medRxiv : the preprint server for health sciences

Published: December 17, 2025

Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer's disease neuroimaging initiative cohort.

Evaluation of plasma p-tau217 biomarkers in detecting amyloid pathology and predicting cognitive outcomes: Observations from Japanese Alzheimer's disease neuroimaging initiative cohort.

Journal: The journal of prevention of Alzheimer's disease

Published: November 11, 2025

Ethnic-specific effects of the LILRB2-LILRB5 locus and newly identified risk loci for Alzheimer's disease in the East Asian population.

Ethnic-specific effects of the LILRB2-LILRB5 locus and newly identified risk loci for Alzheimer's disease in the East Asian population.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: October 31, 2025

Soluble high-molecular-weight amyloid-β species derived from amyloid-β-laden brains induce cerebral β-amyloidosis.

Soluble high-molecular-weight amyloid-β species derived from amyloid-β-laden brains induce cerebral β-amyloidosis.

Journal: Brain communications

Published: October 07, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026